View in EDS

Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years.

Saved in:
Bibliographic Details
Title: Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years.
Authors: Segal EB; Hackensack University Medical Center, Northeast Regional Epilepsy Group, and Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA., Wheless JW; Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Zafar M; Duke University School of Medicine, Durham, North Carolina, USA., Shih EK; Formerly of Neurelis, Inc., San Diego, California, USA., Ngo LY; Neurelis, Inc., San Diego, California, USA., Carrazana E; Neurelis, Inc., San Diego, California, USA.; John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA., Rabinowicz AL; Neurelis, Inc., San Diego, California, USA.; Center for Molecular Biology and Biotechnology (CMBB) in the Charles E. Schmidt Collage of Science at Florida Atlantic University, Boca Raton, Florida, USA.
Corporate Authors: DIAZ.001.008 Study Group
Source: Epilepsia [Epilepsia] 2025 Sep; Vol. 66 (9), pp. 3231-3241. Date of Electronic Publication: 2025 Jul 12.
Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40650667
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Segal+EB%22">Segal EB</searchLink>; Hackensack University Medical Center, Northeast Regional Epilepsy Group, and Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Wheless+JW%22">Wheless JW</searchLink>; Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Zafar+M%22">Zafar M</searchLink>; Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Shih+EK%22">Shih EK</searchLink>; Formerly of Neurelis, Inc., San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Ngo+LY%22">Ngo LY</searchLink>; Neurelis, Inc., San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Carrazana+E%22">Carrazana E</searchLink>; Neurelis, Inc., San Diego, California, USA.; John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.<br /><searchLink fieldCode="AU" term="%22Rabinowicz+AL%22">Rabinowicz AL</searchLink>; Neurelis, Inc., San Diego, California, USA.; Center for Molecular Biology and Biotechnology (CMBB) in the Charles E. Schmidt Collage of Science at Florida Atlantic University, Boca Raton, Florida, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22DIAZ%2E001%2E008+Study+Group%22">DIAZ.001.008 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222983306R%22">Epilepsia</searchLink> [Epilepsia] 2025 Sep; Vol. 66 (9), pp. 3231-3241. <i>Date of Electronic Publication: </i>2025 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2983306R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-1167 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200139580%22">00139580 </searchLink><i>NLM ISO Abbreviation: </i>Epilepsia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40650667
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/epi.18473
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3231
    Titles:
      – TitleFull: Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Segal EB
      – PersonEntity:
          Name:
            NameFull: Wheless JW
      – PersonEntity:
          Name:
            NameFull: Zafar M
      – PersonEntity:
          Name:
            NameFull: Shih EK
      – PersonEntity:
          Name:
            NameFull: Ngo LY
      – PersonEntity:
          Name:
            NameFull: Carrazana E
      – PersonEntity:
          Name:
            NameFull: Rabinowicz AL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1528-1167
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Epilepsia
              Type: main
ResultId 1